Stifel Financial Corp lifted its holdings in Healthequity Inc (NASDAQ:HQY) by 456.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 216,335 shares of the company’s stock after purchasing an additional 177,462 shares during the period. Stifel Financial Corp owned about 0.36% of Healthequity worth $10,979,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Janus Henderson Group PLC raised its stake in Healthequity by 627.9% during the 2nd quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock worth $105,292,000 after acquiring an additional 1,822,732 shares during the period. Eagle Asset Management Inc. bought a new stake in Healthequity during the 3rd quarter worth approximately $36,875,000. FMR LLC raised its stake in Healthequity by 45.6% during the 2nd quarter. FMR LLC now owns 2,235,150 shares of the company’s stock worth $111,378,000 after acquiring an additional 699,728 shares during the period. TimesSquare Capital Management LLC bought a new stake in Healthequity during the 2nd quarter worth approximately $25,822,000. Finally, Wells Fargo & Company MN raised its stake in Healthequity by 49.5% during the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after acquiring an additional 366,925 shares during the period. Hedge funds and other institutional investors own 98.27% of the company’s stock.
In other Healthequity news, major shareholder Berkley Capital, Llc sold 373,500 shares of Healthequity stock in a transaction on Monday, November 6th. The shares were sold at an average price of $53.21, for a total transaction of $19,873,935.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Frank Medici sold 419,504 shares of Healthequity stock in a transaction on Monday, November 6th. The stock was sold at an average price of $52.97, for a total transaction of $22,221,126.88. Following the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at $338,001.57. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,761,117 shares of company stock valued at $91,915,316. 19.00% of the stock is currently owned by insiders.
A number of equities research analysts have commented on HQY shares. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research note on Wednesday, November 8th. Oppenheimer restated a “buy” rating and set a $61.00 target price on shares of Healthequity in a research note on Wednesday, September 6th. Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 price objective on shares of Healthequity in a research report on Tuesday, September 5th. Chardan Capital lifted their price objective on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Finally, BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Healthequity has an average rating of “Buy” and a consensus target price of $58.33.
Healthequity Inc (NASDAQ:HQY) traded down $0.19 during mid-day trading on Tuesday, hitting $46.47. 501,747 shares of the company were exchanged, compared to its average volume of 412,550. Healthequity Inc has a 1 year low of $37.62 and a 1 year high of $55.31. The stock has a market capitalization of $2,850.00, a price-to-earnings ratio of 62.80, a PEG ratio of 1.92 and a beta of 1.74.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The firm had revenue of $56.80 million during the quarter, compared to analyst estimates of $55.27 million. During the same period last year, the firm posted $0.10 earnings per share. Healthequity’s revenue for the quarter was up 31.0% compared to the same quarter last year. sell-side analysts expect that Healthequity Inc will post 0.71 EPS for the current fiscal year.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.